申请人:Catalyst Therapeutics Pty Ltd
公开号:US20170114025A1
公开(公告)日:2017-04-27
The present invention relates to methods for inhibiting necroptosis; screening methods for identifying compounds which inhibit necroptosis; and compounds for the inhibition of necroptosis, which may be useful in the treatment of conditions associated with deregulated necroptosis.